hsd_id_Glycine_max_8766	XP_014619528.1; XP_014621564.1; XP_014623812.1	490; 484; 488	Pfam	PF00650; PF00650; PF00650	CRAL/TRIO domain; CRAL/TRIO domain; CRAL/TRIO domain	IPR001251; IPR001251; IPR001251	CRAL-TRIO lipid binding domain; CRAL-TRIO lipid binding domain; CRAL-TRIO lipid binding domain

>XP_014619528.1
MPSVYMGDRMDNSNSSLSSNSKESSVVVNGKETYKKLLVASRPKGFAQRNYEHLVSLTHGDFGSSAVGRVTFFLLKLAALETVRRFSRSKCPCVWRGLQGLQILVYPPFKWIQRWAPFRGLVKSMQVLSRPLLVLSIATVFTDQPQCSDGTSDCVASHDSEASAELSPAEANLNTSHCEIDPEVLEYENWLTLLNQELENQGISLPERINDDELHRFYTASNNDSSCFLTSIKKTISWRDSYRFLSGEELETWSNMVFWHGSDFSHRPCLIVRLGIACRSLASEDRLQFAQAVISQVEYGVLHLVDASNPQITVLVDCEGLSPLRIPMKMLRSCSSLLLEHFPNRLGCLFIIRLPAIVRVIAQTFIQVLKPSTRKKLKLGGEVYRKVLYDNFPTLPSYLGGSCSCMRCSKIGNWDILQPHATGTSRIDREEDISDNRGLPSLHQSNELDGHQTSNSDQLLRKAVISILVFWVFIALGAGIYDPGSLHLPP
>XP_014621564.1
MGDTVDYSYLSSIPKPGSVVAKNKAYKNLLIASLPKSFVQRNHGHVISLIRGRFGSRDMSGITFFLLKVAALEIIRRFSKRRCPCVWRGLQALQILCYPPFKWIQRWAPFKSLVDGMQVLSRPLLALSIATLFPDLSKCSDGKSDCSTDSQDAVAYSELSPLQVDLNTSQCLTDPKILESEKWLTQLYQELENQGLSLPERINDDELRRFYAASNNDFSCFLTSIKKTIRWRETYRILSEEELKMSSKMVFWHGSDVGQRPCLIIRFGLACSTLTSEDRPRFAQAVISQVEYGVLHLVDADNPQITVLVDCEGLSPVRIPMQIIRSCSSLLKDHFPNRLGCMFVIRLPANVHVIAQTFIQDLKPATRNKLKIEGEMHQKVLSDYMPTLPSYLGGCCTCMKCSNIGQGDMLQTYATGTSRRDGLEDTSDSDNDNEDSPTLHPCDELEGNLYGNYDQLLRTAIVGILIFWVFIALGAVVFDPSNRH
>XP_014623812.1
MGDMVDYSDLSKIPKRGSVVTENKAYKNLLIASLPKSFVQRNHGHLISLVRGRFGIRDVGGITFFLLKVAALEIIRRFSKSRCPCIWRGLQALQILCYPPFKWIQRWEPFKNLVDSMQVLSRPLLALSIATLFSDLSKCSDGKSDCSTDSQDAVAYSELSPLQVDLNTGKCLTDPKILESEKWLTLLIQELENQGLSLPERLLCRINDDELSRFYAASNNDFSCFLTSIKKTIRWRETYRILSEEELKMWSKMVFWHGSDVGHRPCLIVRLGLACSTLTSGDRPRFAQAVISQVEYGVLHLVDAGNPQITVLVDCEGLPPVRIPMQIIRSCSSLLQDHFPNCLGCMFVIRLPANVLVISQTFIQTLEPATRNKLKIEGEMYQKVLSDYLPKLPSYLGGCCTCMKCSNIDHGNMLQTYATGTSRRDGLEDTTDRDNDNEDSPTLHPSNELEGNLYANYDQLLRTAIVGILMFWVFIALGALVFDPSNLH